Abbott Drops $3B On CFR To Bulk Latin America Pharma Biz
Abbott Laboratories will takeover Chile-based CFR Pharmaceuticals in a deal worth roughly $3.33 billion including debt, a move that more than doubles the Illinois-based pharmaceutical company's branded generics in Latin America,...To view the full article, register now.
Already a subscriber? Click here to view full article